Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia.
Neurogenic inflammation is produced by overstimulation of peripheral nociceptor terminals by injury or inflammation of tissues. Excessive activity of sensory neurons produces vasodilation, plasma extravasation and hypersensitivity. Mechanistically, neurogenic inflammation is due to the release of substances from primary sensory nerve terminals that act directly or indirectly at the peripheral terminals, either activating or sensitizing nociceptors, endothelial cells and immunocytes. Notably, small-diameter sensory neurons that are sensitive to capsaicin play a key role in the generation of neurogenic inflammation. The cloning of the vanilloid receptor 1 (TRPV1) has been a breakthrough that has propelled our understanding of the molecular mechanisms involved in neurogenic inflammation. TRPV1 pivotally contributes to the integration of various stimuli and modulates nociceptor excitability, thus making it a true gateway for pain transduction. In addition, TRPV1 is the endpoint target of intracellular signalling pathways triggered by inflammatory mediators. Phosphorylation-induced potentiation of TRPV1 channel activity, along with an incremented TRPV1 surface expression are major events underlying the nociceptor activation and sensitization that leads to thermal hyperalgesia. The important contribution of TRPV1 receptor to the onset and maintenance of neurogenic inflammation has validated it as a therapeutic target for inflammatory pain management. As a result, the development of specific TRPV1 antagonists is a central focus of current drug discovery programs.
Planells-Cases
Rosa
R
Centro de Investigación Príncipe Felipe, FVIB, 46012, Valencia, Spain.
Garcìa-Sanz
Nuria
N
Morenilla-Palao
Cruz
C
Ferrer-Montiel
Antonio
A
D000818:Animals; D006930:Hyperalgesia / Q000139:chemically induced / Q000503:physiopathology*; D007249:Inflammation / Q000139:chemically induced / Q000503:physiopathology*; D018836:Inflammation Mediators / Q000494:pharmacology* / Q000502:physiology; D020932:Nerve Growth Factor / Q000502:physiology; D009475:Neurons, Afferent / Q000502:physiology*; D011494:Protein Kinases / Q000502:physiology; D051381:Rats; D050600:SNARE Proteins / Q000502:physiology; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors / Q000502:physiology*
D018836:Inflammation Mediators; D050600:SNARE Proteins; D050916:TRPV Cation Channels; D020932:Nerve Growth Factor; D011494:Protein Kinases